Sinclair Lab Research ·
This study investigates the AFRAID and FRIGHT clocks in relation to polypharmacy in aging mice. Polypharmacy, defined as the concurrent use of five or more medications, is prevalent among older adults, raising concerns about its impact on healthspan and lifespan. The research conducted by Prof. David Sinclair and colleagues provides insights into how these clocks can predict biological age and mortality in the context of complex medication regimens.
What this study examined
The study focused on male C57BL/6J (B6) mice, which were subjected to different treatment regimens starting at 12 months of age. The researchers administered chronic polypharmacy, monotherapy, or a control treatment, and subsequently assessed the effects of deprescribing some treatments at 21 months. The primary outcomes included comparisons of the AFRAID and FRIGHT clocks, frailty index, and mortality correlations across treatment groups.
Why this matters for longevity research
The findings from this study are significant for longevity research as they explore the intersection of polypharmacy and biological aging. Understanding how multiple medications affect biological aging markers can inform strategies to enhance healthspan and lifespan in aging populations. The study highlights the complexity of treatment effects on aging, suggesting that simply deprescribing medications may not yield straightforward benefits.
Key findings
- The AFRAID and FRIGHT clocks were developed to predict biological age and lifespan in mice.
- Chronic polypharmacy did not show significant differences in AFRAID, FRIGHT, or frailty index compared to control groups.
- Deprescribing some medications led to inconsistent negative impacts on the clocks and mortality.
- FRIGHT and frailty index were associated with mortality, while AFRAID's predictive performance varied.
- Factors such as weight loss influenced the bias in AFRAID's mortality predictions.
- The study suggests that context is crucial when interpreting the utility of these clocks in intervention studies.
- Future research is needed to refine these clocks to minimize bias from specific interventions.
The science behind it
The AFRAID and FRIGHT clocks are rooted in the information theory of aging, which posits that biological age can be inferred from various health metrics. This approach aligns with the NAD+/sirtuin axis, a critical pathway in cellular metabolism and aging. Sirtuins, a family of proteins that regulate cellular health, are influenced by NAD+ levels, which decline with age. The study's findings underscore the importance of understanding how various interventions, including polypharmacy, impact these biological aging markers and their correlation with health outcomes.
How it fits into the longevity field
This research contributes to a growing body of literature examining the effects of medications on aging. Other studies have explored interventions such as caloric restriction and exercise, which also influence the NAD+/sirtuin pathway and overall healthspan. By situating the AFRAID and FRIGHT clocks within this broader context, researchers can better understand the implications of polypharmacy on aging and explore potential strategies for optimizing treatment in older adults.
Practical takeaways
For researchers and informed readers, this study emphasizes the need for careful consideration of polypharmacy in aging research. The AFRAID and FRIGHT clocks may provide valuable insights, but their predictive capabilities can be influenced by treatment context. Future studies should aim to refine these tools to enhance their accuracy in predicting outcomes related to aging and healthspan.
FAQ
What are the AFRAID and FRIGHT clocks?
The AFRAID clock predicts lifespan, while the FRIGHT clock estimates biological age based on health metrics.
How does polypharmacy affect aging?
Polypharmacy can complicate health outcomes in aging populations, potentially impacting biological aging markers.
What is the significance of deprescribing medications?
Deprescribing may not always lead to improved health outcomes, as shown by the inconsistent effects on aging clocks.
Source: PubMed · J Gerontol A Biol Sci Med Sci · published 2022-07-05.